User profiles for H. Hackl

Hubert Hackl

Medical University of Innsbruck
Verified email at i-med.ac.at
Cited by 15303

Computational genomics tools for dissecting tumour–immune cell interactions

H Hackl, P Charoentong, F Finotello… - Nature Reviews …, 2016 - nature.com
Recent breakthroughs in cancer immunotherapy and decreasing costs of high-throughput
technologies have sparked intensive research into tumour–immune cell interactions using …

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

G Bindea, B Mlecnik, H Hackl, P Charoentong… - …, 2009 - academic.oup.com
We have developed ClueGO, an easy to use Cytoscape plug-in that strongly improves
biological interpretation of large lists of genes. ClueGO integrates Gene Ontology (GO) terms as …

Next-generation computational tools for interrogating cancer immunity

F Finotello, D Rieder, H Hackl, Z Trajanoski - Nature Reviews Genetics, 2019 - nature.com
The remarkable success of cancer therapies with immune checkpoint blockers is
revolutionizing oncology and has sparked intensive basic and translational research into the …

[PDF][PDF] Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade

…, M Angelova, C Mayer, M Efremova, D Rieder, H Hackl… - Cell reports, 2017 - cell.com
The Cancer Genome Atlas revealed the genomic landscapes of human cancers. In parallel,
immunotherapy is transforming the treatment of advanced cancers. Unfortunately, the …

[HTML][HTML] Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia

H Hackl, K Astanina, R Wieser - Journal of hematology & oncology, 2017 - Springer
Background The majority of individuals with acute myeloid leukemia (AML) respond to initial
chemotherapy and achieve a complete remission, yet only a minority experience long-term …

[HTML][HTML] Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

…, C Mayer, C Plattner, G Laschober, D Rieder, H Hackl… - Genome medicine, 2019 - Springer
We introduce quanTIseq, a method to quantify the fractions of ten immune cell types from bulk
RNA-sequencing data. quanTIseq was extensively validated in blood and tumor samples …

[HTML][HTML] Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for …

M Angelova, P Charoentong, H Hackl, ML Fischer… - Genome biology, 2015 - Springer
… Major differences in the enrichment of TIL subpopulations could be observed in the MSI-H,
MSS^, and the four MSS subtypes. MSI-H tumors were enriched with all CD4 and CD8 …

[PDF][PDF] Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations

…, J Wang, V Klepsch, TE Adolph, SJ Reider, H Hackl… - Cell host & …, 2016 - cell.com
High mucosal and fecal concentrations of the antimicrobial siderophore-binding peptide
Lipocalin-2 (Lcn2) are observed in inflammatory bowel disease. However, Lcn2 function in …

Interfacial microstructure and mechanical properties of aluminium–zinc-coated steel joints made by a modified metal inert gas welding–brazing process

HT Zhang, JC Feng, P He, H Hackl - Materials characterization, 2007 - Elsevier
The microstructure and properties of aluminium–zinc coated steel lap joints made by a
modified metal inert gas CMT welding–brazing process was investigated. It was found that the …

[HTML][HTML] Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution

…, V Klepsch, P Charoentong, F Finotello, H Hackl… - Nature …, 2018 - nature.com
The cancer immunoediting hypothesis postulates a dual role of the immune system: protecting
the host by eliminating tumor cells, and shaping the tumor by editing its genome. Here, we …